Pitch Perception and Memory: Deficits and Training (Pitch_Train)

April 16, 2024 updated by: Hospices Civils de Lyon
Pitch perception and memory are central in auditory cognition, in particular for sound source segregation and recognition, speech prosody and music processing. Here the investigator assess pitch perception and memory in hearing-impaired listeners wearing cochlear implant(s) and listeners with congenital amusia, both compared with control listeners. Behavioral, EEG, and MEG measures are collected in audio and audio-visual contexts to characterize pitch processing deficits, and test a pitch training program.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

960

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, 69500
        • Recruiting
        • Lyon Neuroscience Research Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • Anne CACLIN, PhD
        • Sub-Investigator:
          • Barbara Tillmann, PhD
        • Sub-Investigator:
          • Aurélie BIDET-CAULET, PhD
        • Sub-Investigator:
          • Annie MOULIN, PhD
        • Sub-Investigator:
          • Eric TRUY, MD, PhD
        • Sub-Investigator:
          • Ruben HERMANN, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

For adult participants:

  • Aged between 18 and 90
  • Absence of neurological and psychiatric disorders
  • No major cognitive deficit, ability to understand and apply study instructions
  • Motivation to participate efficiently in the study
  • Written informed consent to participant in the study
  • Affiliated to social security
  • Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility

For underage participants:

  • Subject aged 5 years and over
  • Informed consent of parents or guardians for the participation of the child being studied
  • No neurological or psychiatric history
  • Without major cognitive impairment and ability to understand and apply setpoint.
  • Subject affiliated to a social security scheme
  • Motivation to participate effectively in the project

Exclusion Criteria:

For adult participants:

  • Age below 18 or above 90
  • Pregnant or breast-feeding woman

For underage participants:

- Pregnant or nursing minors

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cochlear implant users
In both arms a pitch training protocol and a visuo-spatial training protocol are applied.
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
Listening tests. EEG/MEG/MRI recordings
Experimental: Participants with Congenital Amusia
In both arms a pitch training protocol and a visuo-spatial training protocol are applied.
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
Listening tests. EEG/MEG/MRI recordings
Experimental: Control Participants
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of ~20 minutes performed at home over a period of 15 weeks.
Listening tests. EEG/MEG/MRI recordings

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentages of correct responses in listening tests
Time Frame: during procedure
during procedure
reaction times in listening tests
Time Frame: during procedure
during procedure
Event-Related Fields
Time Frame: during procedure
MEG measurements
during procedure
Oscillations
Time Frame: during procedure
MEG measurements
during procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentages of correct responses
Time Frame: Day 0
Performance in listening tests in audio contexts
Day 0
percentages of correct responses
Time Frame: Day 0
Performance in listening tests in audio-visual contexts
Day 0
reaction times
Time Frame: Day 0
Performance in listening tests in audio contexts
Day 0
reaction times
Time Frame: Day 0
Performance in listening tests in audio-visual contexts
Day 0
Event-Related Fields
Time Frame: Day 0
EEG measurements
Day 0
Oscillations
Time Frame: Day 0
EEG measurements
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne CACLIN, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2019

Primary Completion (Estimated)

October 26, 2025

Study Completion (Estimated)

October 26, 2025

Study Registration Dates

First Submitted

October 12, 2018

First Submitted That Met QC Criteria

October 12, 2018

First Posted (Actual)

October 16, 2018

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL18_0632
  • 2018-A02670-55 (Other Identifier: ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cochlear Implants

Clinical Trials on Listening tests. Pitch training protocol

3
Subscribe